These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7022891)

  • 1. Models of specific unresponsiveness in adult animals: potential clinical application.
    Monaco AP; Wood ML
    Transplant Proc; 1981 Mar; 13(1 Pt 1):547-55. PubMed ID: 7022891
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of cyclosporine on the induction of unresponsiveness in antilymphocyte serum-treated, marrow-injected mice.
    Wood ML; Gottschalk R; Monaco AP
    Transplantation; 1988 Sep; 46(3):449-51. PubMed ID: 3047934
    [No Abstract]   [Full Text] [Related]  

  • 3. Models of specific unresponsiveness to tissue allografts in antilymphocyte serum (ALS) treated mice.
    Wood ML; Monaco AP
    Transplant Proc; 1978 Jun; 10(2):379-87. PubMed ID: 354127
    [No Abstract]   [Full Text] [Related]  

  • 4. Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion.
    Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP
    Transplant Proc; 1996 Dec; 28(6):3269. PubMed ID: 8962269
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of rapamycin on induction of unresponsiveness in ALS-treated, marrow-injected mice.
    Bobbio SA; Wood ML; Monaco AP
    Transplant Proc; 1993 Feb; 25(1 Pt 1):717-8. PubMed ID: 8438453
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporine and unresponsiveness to allografts induced by polyclonal antilymphocyte serum and donor-specific bone marrow.
    Monaco AP; Wood ML; Maki T; Hartner W; De Fazio S; Gozzo JJ
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):36-48. PubMed ID: 2968700
    [No Abstract]   [Full Text] [Related]  

  • 7. Unresponsiveness to rat cardiac allografts induced by intrathymic injection of donor bone marrow cells and short course of immunosuppression.
    Hara Y; Matsuura T; Imanishi M; Tahara H; Kurita T
    Transplant Proc; 1994 Dec; 26(6):3226-8. PubMed ID: 7527955
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies in rodents on the use of polyclonal antilymphocyte serum and donor-specific bone marrow to induce specific unresponsiveness to skin allografts.
    Monaco AP
    Transplant Proc; 1991 Aug; 23(4):2061-7. PubMed ID: 1871820
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of antilymphocyte serum-treated bone marrow on skin graft survival in rats.
    Sato T; Amada N; Fujimori K; Sawada H; Satake M; Taguchi Y; Kasai M
    Transplant Proc; 1987 Feb; 19(1 Pt 1):578. PubMed ID: 3274824
    [No Abstract]   [Full Text] [Related]  

  • 10. Specificity requirement of donor bone marrow cells that prolong allograft survival: implications for a veto cell mechanism of action.
    De Fazio SR; Markees TG; Hartner WC; Gozzo JJ
    Transplant Proc; 1995 Feb; 27(1):171-3. PubMed ID: 7878960
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of rapamycin on islet and skin xenograft survival.
    Bobbio SA; Porter JG; Monaco AP
    Transplant Proc; 1993 Aug; 25(4):2745-6. PubMed ID: 8356733
    [No Abstract]   [Full Text] [Related]  

  • 12. Organ-specific tolerance induced by intrathymic injection of donor bone marrow cells and FK 506 or antilymphocyte serum in rat heart transplantation.
    Matsuura T; Imanishi M; Hara Y; Tahara H; Kanda H; Kurita T
    Transplant Proc; 1994 Aug; 26(4):1962-3. PubMed ID: 7520616
    [No Abstract]   [Full Text] [Related]  

  • 13. Effectiveness of intrathymic inoculation of soluble antigens in the induction of specific unresponsiveness to rat islet allografts without transient recipient immunosuppression.
    Oluwole SF; Jin MX; Chowdhury NC; Ohajekwe OA
    Transplantation; 1994 Nov; 58(10):1077-81. PubMed ID: 7974714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of operational tolerance by random blood transfusion combined with anti-CD4 antibody therapy. A protocol with significant clinical potential.
    Bushell A; Morris PJ; Wood KJ
    Transplantation; 1994 Jul; 58(2):133-9. PubMed ID: 8042231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of graft inoculation with donor bone marrow cells on kidney allograft survival in antilymphocyte serum-treated rats.
    Otsu I; Gottschalk R; Monaco AP
    Transplant Proc; 1994 Oct; 26(5):3060. PubMed ID: 7940962
    [No Abstract]   [Full Text] [Related]  

  • 16. Improved large burn therapy with reduced mortality following an associated septic challenge by early excision and skin allografting using donor-specific tolerance.
    Garrison JL; Thomas F; Cunningham P
    Transplant Proc; 1995 Feb; 27(1):1416-8. PubMed ID: 7878931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin allograft survival following intrathymic injection of donor bone marrow.
    Cober SR; Randolph MA; Lee WP
    J Surg Res; 1999 Aug; 85(2):204-8. PubMed ID: 10423320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse skin allograft model for study of pregraft blood transfusion.
    Maki T; Okazaki H; Wood ML; Monaco AP
    Transplant Proc; 1982 Jun; 14(2):394-6. PubMed ID: 7051485
    [No Abstract]   [Full Text] [Related]  

  • 19. Cloned veto cells as immunoregulators.
    Takeda Y; Yanagie H; Maki T
    Transplant Proc; 1993 Aug; 25(4):2743-4. PubMed ID: 8356732
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of peripheral blood components on allograft survival.
    Wakely E; Shelby J; Corry RJ
    Transplantation; 1985 Jul; 40(1):113-4. PubMed ID: 3892790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.